Year | Localized stage | Total | ||
---|---|---|---|---|
Low risk | Intermediate risk | High risk | ||
2017 | 2 (0.4 ‰) | 1 (0.2 ‰) | 2 (0.4 ‰) | 5 (1.0 ‰) |
2016 | 1 (0.2 ‰) | 2 (0.3 ‰) | 3 (0.5 ‰) | 6 (1.0 ‰) |
2015 | 1 (0.2 ‰) | 3 (0.5 ‰) | 4 (0.7 ‰) | 8 (1.5 ‰) |
2014 | 0 (0.0 ‰) | 5 (0.8 ‰) | 9 (1.4 ‰) | 14 (2.2 ‰) |
2013 | 4 (0.6 ‰) | 1 (0.2 ‰) | 8 (1.3 ‰) | 13 (2.0 ‰) |
Total | 8 (0.3 ‰) | 12 (0.4 ‰) | 26 (0.9 ‰) | 46 (1.6 ‰) |